Predictors of Prognosis in IBD Patients
Recruiting
Observational Study
Inflammatory Bowel Diseases
Ulcerative Colitis
Crohn Disease
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 100 (estimated)
- Sponsor
- Seoul National University Bundang Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
A study of clinical characteristics and potential prognostic factors in inflammatory bowel disease
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* control group: Patients who do not have colitis, cancer, and advanced polyp (the number of polyps ≥ 3, the size of polyps ≥ 1cm, high-grade adenoma, villous adenoma)
* TNF-α inhibitor-naive IBD group: IBD patients who do not have a history of TNF-α inhibitor treatment
* TNF-α …
Contacts